Enzolytics

Manufacturing · Texas, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

PO Box 5756, Frisco, Texas, United State...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Enzolytics

Enzolytics, Inc. is a publicly traded biotech and drug development company based in Texas, focused on the commercialization of proprietary proteins and fully human monoclonal antibodies for the treatment of debilitating infectious diseases. The company's lead compound, ITV-1 (Immune Therapeutic Vaccine-1), is a clinically tested anti-HIV therapeutic, and its proprietary cell line produces human IgG1 monoclonal antibodies that target and neutralize the HIV virus through non-toxic passive immunotherapy. Beyond HIV, Enzolytics is advancing therapeutics targeting a broad range of infectious diseases, including Coronavirus (SARS-CoV-2), Ebola, Influenza A and B, RSV, Rabies, Herpes, and Feline Leukemia Virus, among others. The company leverages artificial intelligence platforms to accelerate drug discovery and development, and operates through subsidiaries including Biogenysis, Inc. and Virogentics, Inc. Enzolytics trades on the OTC Pink market under the ticker symbol ENZC.Explore more
Popular SearchesEnzolytics IncSIC Code 28,283NAICS Code 32,325Show more

Enzolytics Org Chart

SS
United States flag for contact location.

Chief Executive Officer

PhoneEmail

Is Enzolytics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Enzolytics

Compare insights from companies similar to Enzolytics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Enzolytics

<$5M
11-50
Private
-
-
$6.5M
11-50
Private
-
2019
MD
MITKO-perso DimitrovExecutive Vice President and CSO
$5.3M
11-50
Private
$83.5M
2005
<$5M
11-50
Private
$19.5M
1998
Tony Leighton, Chief Marketing Officer at Trellis Bioscience
Tony LeightonChief Marketing Officer
<$5M
11-50
Private
-
2018
JS
Jane SeagalSenior Vice President
<$5M
1-10
Private
$35.5M
2004
WC
Witold CieplakVice President, Development
<$5M
1-10
Private
-
2019
N/A
Illustration of an envelope

Enzolytics Tech Stack

A closer look at the technologies used by Enzolytics

Top Manufacturing Companies

Frequently Asked Questions Regarding Enzolytics

What is Enzolytics's official website?
Enzolytics's official website is www.enzolytics.com
What is Enzolytics's Revenue?
Enzolytics's revenue is <$5 Million
What is Enzolytics's SIC code?
Enzolytics's SIC: 28,283
What is Enzolytics's NAICS code?
Enzolytics's NAICS: 32,325
How many employees does Enzolytics have?
Enzolytics has 11-50 employees
What industry does Enzolytics belong to?
Enzolytics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Enzolytics competition?
Enzolytics top competitors include: Trellis Bioscience, Theraclone Sciences, Abound Bio, Immunomic Therapeutics
What technology does Enzolytics use?
Some of the popular technologies that Enzolytics uses are: WordPress.org, PHP, F5 Silverline DDoS Protection, Google Font API
What does Enzolytics do?

Enzolytics, Inc. is a publicly traded biotech and drug development company based in Texas, focused on the commercialization of proprietary proteins and fully human monoclonal antibodies for the treatment of debilitating infectious diseases. The company's lead compound, ITV-1 (Immune Therapeutic Vaccine-1), is a clinically tested anti-HIV therapeuti... c, and its proprietary cell line produces human IgG1 monoclonal antibodies that target and neutralize the HIV virus through non-toxic passive immunotherapy. Beyond HIV, Enzolytics is advancing therapeutics targeting a broad range of infectious diseases, including Coronavirus (SARS-CoV-2), Ebola, Influenza A and B, RSV, Rabies, Herpes, and Feline Leukemia Virus, among others. The company leverages artificial intelligence platforms to accelerate drug discovery and development, and operates through subsidiaries including Biogenysis, Inc. and Virogentics, Inc. Enzolytics trades on the OTC Pink market under the ticker symbol ENZC.Read More

Is Enzolytics a public company?
Enzolytics is private company therefore does not currently have an official ticker symbol
See more information about Enzolytics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.